Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
570
datasets available to search
ShareScore release 0.7.1
Dataset results
570 results for “psychiatric”
The deployment of temporary nurses and its association with permanent nurses' outcomes in Swiss psychiatric hospitals: A secondary analysis.
<p>The objective of this analysis was to investigate the frequency of temporary nurses’ deployment and their association with nurse staffing levels and permanent nurses’ outcomes in Swiss psychiatric hospitals. The data is based on the Match<sup>RN</sup> Psychiatry study including 79 psychiatric units and 651 nurses and provides unit level frequency of temporary nurses’ deployment and individual nurse level data on staffing levels and permanent nurses’ outcomes namely job satisfaction, burnout, and intention to leave organization or profession. The data was collected in 2019 and 2020. We provide the unit and nurse-level dataset, a codebook and the r code to replicate the analyses of the paper. You can find the paper here: <a href="https://peerj.com/articles/15300/">https://peerj.com/articles/15300/</a> </p>
Brain functional connectivity data in anesthetized participants and patients with neuropathological or psychiatric diagnoses
<p>Five fMRI datasets were collected from independent research sites including: propofol deep sedation (PDS; drug effect site concentration= ~2.4 μg/ml) in Dataset-1, propofol general anesthesia (PGA; drug effect site concentration= 4.0 μg/ml) in Dataset-2, ketamine anesthesia (KA) in Dataset-3, unresponsive wakefulness syndrome (UWS) in Dataset-4, and schizophrenia (SCHZ), bipolar disorder (BD), and attentional deficit hyperactivity disorder (ADHD) in Dataset-5. Following fMRI data preprocessing, the fMRI time courses were extracted from 400 cortical areas according to a well-established brain parcellation scheme (Schaefer's 400 ROIs). A connectivity matrix was then calculated using Pearson correlation resulting in a 400x400 connectivity matrix for each participant and each condition.</p>
Detection and analysis of complex structural variation in human genomes across populations and in brains of donors with psychiatric disorders
Open the record for dataset details and reuse information.
Psychiatric manifestations and associated risk factors among hospitalized patients with COVID-19 in Edo State, Nigeria: A Cross-sectional Study
<p>The Coronavirus Disease 2019 (COVID-19) has had devastating effects globally. These effects are likely to result in mental health problems at different levels. Although studies have reported the mental health burden of the pandemic on the general population and frontline health workers, the impact of the disease on the mental health of patients in COVID-19 treatment and isolation centres have been understudied in Africa.</p> <p>We estimated the prevalence of depression and anxiety and associated risk factors in hospitalized persons with COVID-19. A cross-sectional survey was conducted among 489 patients with COVID-19 at the three government-designated treatment and isolation centres in Edo State, Nigeria. The 9-item Patient Health Questionnaire (PHQ-9) and the Generalized Anxiety Disorder-7 (GAD-7) tool were used to assess depression and anxiety respectively. Binary logistic regression was applied to determine risk factors of depression and anxiety. Results Of the 489 participants, 49.1% and 38.0% had depressive and anxiety symptoms respectively. The prevalence of depression, anxiety, and combination of both were 16.2%, 12.9% and 9.0% respectively. Moderate-severe symptoms of COVID-19, ≥14 days in isolation, worrying about the outcome of infection and stigma increased the risk of having depression and anxiety. Additionally, being separated/divorced increased the risk of having depression and having comorbidity increased the risk of having anxiety.</p> <p>A substantial proportion of our participants experienced depression, anxiety and a combination of both especially in those who had the risk factors we identified. The findings underscore the need to address modifiable risk factors for psychiatric manifestations early in the course of the disease and integrate mental health interventions and psychosocial support into COVID-19 management guidelines. --</p>
Increase in coercive measures in psychiatric hospitals during the COVID-19 Pandemic
<p class="MsoNormal"><strong><span>Objective</span></strong><span>: To examine whether the pandemic in 2020 caused changes in psychiatric hospital cases, the percentage of patients exposed to coercive interventions, and aggressive incidents. </span></p> <p class="MsoNormal"><span><strong>Results: </strong>The number of cases in adult psychiatry decreased by 7.6% from 105,782 to 97,761. The percentage of involuntary cases increased from 12.3 to 14.1%, and the absolute number of coercive measures increased by 4.7% from 26,269 to 27,514. The percentage of cases exposed to any kind of coercive measure increased by 24.6% from 6.5 to 8.1%, and the median cumulative duration per affected case increased by 13.1% from 12.2 to 13.8 hrs, where seclusion increased more than mechanical restraint. The percentage of patients with aggressive incidents, collected in 10 hospitals, remained unchanged. </span></p> <p class="MsoNormal"><span><strong>Conclusions: </strong>While voluntary cases decreased considerably during the pandemic, involuntary cases increased slightly. However, the increased percentage of patients exposed to coercion is not only due to a decreased percentage of voluntary patients, as the duration of coercive measures per case also increased. The changes that indicate deterioration in treatment quality were probably caused by the multitude of measures to manage the pandemic. The focus of attention and internal rules as well have shifted from prevention of coercion to prevention of infection.</span></p>
Table 2. Studies on psychiatric side effects of fluoroquinolones. The risk of bias and study quality assessed with the Effective Public Health Practice Project's Quality Assessment Tool for Quantitative Studies (QATQS) was presented as the global rating for each publication (3 – weak).
<p>Studies on psychiatric side effects of fluoroquinolones. The risk of bias and study quality assessed with the Effective Public Health Practice Project’s Quality Assessment Tool for Quantitative Studies (QATQS) was presented as the global rating for each publication (3 – weak).</p>
Racial Disparities in Antidepressant Treatment After a Psychiatric Consultation
ClinicalTrials.gov study NCT06799078. IPD Sharing: UNDECIDED. Countries: 1. Publications: 15.
Study To Evaluate Cardiac Assessments Following Different Treatments Of Smoking Cessation Medications In Subjects With And Without Psychiatric Disorders.
ClinicalTrials.gov study NCT01574703. IPD Sharing: Not stated. Countries: 16. Publications: 1.
Telepsychiatry to Enable Expedited Disposition of Psychiatric Emergencies
ClinicalTrials.gov study NCT05771545. IPD Sharing: NO. Countries: 1. Publications: 1.
Tailored Response to Psychiatric Comorbidity to Improve HIV Care Engagement in the United States
ClinicalTrials.gov study NCT04163341. IPD Sharing: NO. Countries: 1. Publications: 1.
Brain Imaging of Childhood Onset Psychiatric Disorders, Endocrine Disorders and Healthy Volunteers
ClinicalTrials.gov study NCT00001246. IPD Sharing: YES. Countries: 1. Publications: 24.
Sleep in Psychiatric Care (SIP): A Transdiagnostic Group-based Sleep-school as Treatment for Comorbid Insomnia
ClinicalTrials.gov study NCT04463498. IPD Sharing: YES. Countries: 1. Publications: 1.
Study Evaluating The Safety And Efficacy Of Varenicline and Bupropion For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
ClinicalTrials.gov study NCT01456936. IPD Sharing: Not stated. Countries: 16. Publications: 14.
Sleep in Psychiatric Care (SIP): Treatment for Comorbid Delayed Sleep-Wake Phase Disorder (DSWPD)
ClinicalTrials.gov study NCT05177055. IPD Sharing: YES. Countries: 1. Publications: 1.
Adaptation Plan for Culturally Competent Care (PAACI) in the Acute Psychiatric Unit.
ClinicalTrials.gov study NCT06879093. IPD Sharing: NO. Countries: 1. Publications: 5.
Observational Study to Compare Outcomes of Different Psychiatric Treatment of Suicidal Adolescents
ClinicalTrials.gov study NCT04625686. IPD Sharing: NO. Countries: 1. Publications: 4.
Pain, Psychiatric Disorders, and Disability Among Veterans With and Without Polytrauma
ClinicalTrials.gov study NCT00645970. IPD Sharing: Not stated. Countries: 1. Publications: 8.
Increase in coercive measures in psychiatric hospitals during the COVID-19 Pandemic
Open the record for dataset details and reuse information.
Psychiatric manifestations and associated risk factors among hospitalized patients with COVID-19 in Edo State, Nigeria: A Cross-sectional Study
Open the record for dataset details and reuse information.
Hemispheric divergence of interoceptive processing across psychiatric disorders
Open the record for dataset details and reuse information.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.